Retsevmo 40 mg

Retsevmo 40 mg is a medicine authorised by Swissmedic under authorisation number 67862. The authorisation holder is Eli Lilly (Suisse) SA. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 08 February 2021 and the authorisation is limited until 19 December 2029. ATC code L01EX22 places the medicine in the group Antineoplastic agents.

  • Dispensing category A
  • Authorisation number 67862
  • ATC L01EX22
  • Synthetic medicines
Authorisation data
Authorisation number67862
NameRetsevmo 40 mg
Full nameRetsevmo 40 mg, gélules
Authorisation holderEli Lilly (Suisse) SA
Medicinal product codeSynthetic medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeL01EX22
First authorisation08 February 2021
Authorisation validity19 December 2029
Strengths
No.NameDispensing categoryAuthorisation date
1Retsevmo 40 mg, gélulesA08 February 2021
2Retsevmo 80 mg, gélulesA08 February 2021

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
456Kapsel(n)L01EX2207.16.1.A
556Kapsel(n)L01EX2207.16.1.A
6112Kapsel(n)L01EX2207.16.1.A

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Retsevmo 40 mg authorised in Switzerland?

Yes. Retsevmo 40 mg is authorised by Swissmedic under authorisation number 67862, data as of 01 September 2026. The authorisation is limited until 19 December 2029.

Which dispensing category does Retsevmo 40 mg have?

Retsevmo 40 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Retsevmo 40 mg?

The authorisation holder is Eli Lilly (Suisse) SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com